Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  HYLAND ROSEMARY G.
 2. Date of Event Requiring Statement (Month/Day/Year)
04/24/2012		 3. Issuer Name and Ticker or Trading Symbol
TOMPKINS FINANCIAL CORP [TMP]
(Last)
(First)
(Middle)
C/O TOMPKINS FINANCIAL CORPORATION, P O BOX 460		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP, Human Resources
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

ITHACA, NY 14851		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1,511
D (1)
 
Common Stock 2,607
I
By 401(K)/ESOP

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Incentive Stock Option (Right to Buy)   (2) 05/03/2014 Common Stock 3,594 $ 35.77 D  
Incentive Stock Option (Right to Buy)   (3) 01/23/2016 Common Stock 3,630 $ 38.54 D  
Incentive Stock Option (Right to Buy)   (3) 11/29/2017 Common Stock 3,300 $ 37.28 D  
Stock Appreciation Rights (SAR)   (4) 09/17/2019 Common Stock 1,760 $ 41.71 D  
Stock Appreciation Rights (SAR)   (4) 08/19/2021 Common Stock 1,300 $ 37 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
HYLAND ROSEMARY G.
C/O TOMPKINS FINANCIAL CORPORATION
P O BOX 460
ITHACA, NY 14851		       SVP, Human Resources  

Signatures

Rosemary G. Hyland 05/03/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes 608 shares of Restricted Stock granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. Restricted Stock grants have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. The grant will expire ten years from the date of the grant.
(2) The stock option becomes exercisable in four annual installments commencing two years after the date of grant.
(3) The stock option becomes exercisable in six annual installments commencing two years after the date of grant.
(4) Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.